Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-5920 in involutional osteoporosis (multicenter double-blind RCT)
jRCT2080220084Phase 3
- Sponsor
- Ono Pharmaceutical
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of minodronic acid in involutional osteoporosis (2 arms), sponsored by Ono Pharmaceutical.
02
Drugs
minodronic acid
03
Conditions
involutional osteoporosis
Beyond the preview
Go deeper on jRCT2080220084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220084.